Preimplantation Genetic Diagnosis: State of the Art
Preimplantation genetic diagnosis (PGD) is used to analyze embryos genetically before their transfer into the uterus and offers couples at risk the chance to have an unaffected child, without facing termination of pregnancy. Embryos are obtained by in vitro fertilization with intracytoplasmic sperm injection (ICSI), and are biopsied mostly on day 3; blastocyst biopsy is mentioned as a possible alternative; the genetic analysis is performed on one or two blastomeres, by fluorescent in situ hybridization (FISH) for cytogenetic diagnosis, or polymerase chain reaction (PCR) for moleculardiagnosis (Basille, et al., 2009). PGD requires a close collaboration between obstetricians, fertility specialists, IVF laboratory and human geneticists. It needs intensive effort, expensive techniques and is demanding for the patients, but it offers tremendous opportunity for couples whose previous child has exhibited genetic abnormalities.
Children as Hematopoietic Stem Cell Donors
This article isn't directly related to PGD but, based on the last article, it seemed relevant to find information on the ethical implications that are relevant to using PGD to generate umbilical cords for older siblings. Children often serve as hematopoietic stem cell donors, most commonly for their siblings. HLA-matched biological siblings are generally preferred as donors because of reduced risks of transplant-related complications as compared with unrelated donors (Committee on Bioethics, 2010)....
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now